Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2

The novel coronavirus pneumonia (COVID-19) pandemic is a great threat to human society and now is still spreading. Although several vaccines have been authorized for emergency use, only one recombinant subunit vaccine has been permitted for widespread use. More subunit vaccines for COVID-19 should b...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yi-Sheng, Zhou, Jing-Jing, Zhu, Han-Ping, Xu, Fang, Zhao, Wen-Bin, Lu, Hang-Jing, Wang, Zhen, Chen, Shu-Qing, Yao, Ping-Ping, Jiang, Jian-Min, Zhou, Zhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541238/
https://www.ncbi.nlm.nih.gov/pubmed/34696367
http://dx.doi.org/10.3390/v13101936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541238/
https://www.ncbi.nlm.nih.gov/pubmed/34696367
http://dx.doi.org/10.3390/v13101936

Ejemplares similares